Skin Warts during Fingolimod Treatment in Patients with Multiple Sclerosis
Conclusions: In conclusion, we report five patients who developed skin warts during fingolimod therapy, especially HPV-related, for an overall incidence of 2.2%. Larger cohorts are needed to confirm this proposed higher susceptibility of fingolimod-treated patients to HPV infections.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Gilenya | Hepatitis | Hepatitis C | Herpes | Men | Meningitis | Multiple Sclerosis | Neurology | Respiratory Medicine | Sarcomas | Skin | Warts